PRESS RELEASE published on 09/29/2025 at 07:30, 11 months 12 days ago Exosens décroche un contrat majeur de 17 000 monoculaires de vision nocturne nouvelle génération avec l'armée espagnole Exosens signe un contrat majeur avec l'armée espagnole pour 17,000 monoculaires de vision nocturne nouvelle génération Contrat Exosens Vision Nocturne Armée Espagnole Monoculaires
BRIEF published on 07/30/2025 at 08:50, 1 year 1 month ago Exosens publie son rapport financier semestriel 2025 Innovation Rapport Financier Exosens 2025 Technologies Électro-optiques
BRIEF published on 07/30/2025 at 08:50, 1 year 1 month ago Exosens Releases 2025 Half-Year Financial Report Innovation Financial Report Electro-optical Technologies Exosens 2025
PRESS RELEASE published on 07/30/2025 at 08:45, 1 year 1 month ago Exosens announces the publication of its 2025 half-year financial report Exosens announces the publication of its 2025 half-year financial report. The report is available on the company's website. Exosens is an innovator in optoelectronics French Financial Markets Authority Exosens Optoelectronics 2025 Half-year Financial Report Innovator
BRIEF published on 05/26/2025 at 17:50, 1 year 3 months ago Exosens Shareholders Approve Key Resolutions at General Meeting Governance General Meeting Exosens Dividends 2024 Financials
BRIEF published on 05/26/2025 at 17:50, 1 year 3 months ago Les actionnaires d'Exosens approuvent les résolutions clés lors de l'assemblée générale Gouvernance Assemblée Générale Exosens Dividendes Résultats Financiers 2024
PRESS RELEASE published on 05/26/2025 at 17:45, 1 year 3 months ago Exosens: Combined General Meeting of 23 May 2025 Exosens shareholders approve 2024 financial statements and dividend payment at the Combined General Meeting on 23 May 2025 in France Shareholders Financial Statements Governance Exosens Dividends
BRIEF published on 04/28/2025 at 07:35, 1 year 4 months ago Exosens annonce une forte croissance de son chiffre d'affaires au premier trimestre 2025, portée par la demande du secteur de la défense Croissance Des Revenus Marché De La Défense Intensificateurs D'image Acquisition De Noxant Marge Brute Ajustée
BRIEF published on 04/28/2025 at 07:35, 1 year 4 months ago Exosens Reports Robust Q1 2025 Revenue Growth Driven by Defense Demand Revenue Growth Defense Market Image Intensifiers Noxant Acquisition Adjusted Gross Margin
Published on 09/11/2026 at 17:00, 2 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 3 hours 35 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 4 hours 30 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 45 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 23 hours 30 minutes ago Availability of the 2026 Interim Financial Report
